Gliotransmitter

• Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2—Metabolome, immunome, synaptome (02 Sep 2024)
  
• Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)